
gene
Audioholics Master Chief
Administrator
Apple Inc is embroiled in a PR nightmare after the Cupertino computer company received International Trade Commission orders to stop selling new Apple Watches due to infringement of Masimo intellectual property. Meanwhile, Masimo CEO, Joe Kiani exposes Apple's poor implementation of its blood-oxygen monitoring technology.
Masimo CEO Joe Kiani is an outspoken business leader and philanthropist in the healthcare industry. By reputation Kiani’s gifted with the riz as the kids call it these days and he’s already delivered choice words to and about Apple:
Read: New Apple Watch Infringes Denon/B&W Parent, Masimo's IP
Masimo CEO Joe Kiani is an outspoken business leader and philanthropist in the healthcare industry. By reputation Kiani’s gifted with the riz as the kids call it these days and he’s already delivered choice words to and about Apple:
Will Apple Buy out Masimo or will they just hand Masimo a big bag of money to go away?“Apple’s internal documents that we saw in court showed that they knew their product wasn’t good enough to be used medically and they didn’t even seek FDA clearance because of that. Their own testing showed they got two measurements a day on 37% of the people. That’s it! We get over 70K measurements a day on everyone. And they pushed it out anyway, because as their email showed, because they thought in the chaos of COVID. This is a quotation, that they could get market share away from Fitbit.”
Read: New Apple Watch Infringes Denon/B&W Parent, Masimo's IP